Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Controlled Clinical Study to Investigate the Efficacy and Tolerability of Subcutaneous Treprostinil Sodium in Patients With Severe Non-operable Chronic Thromboembolic Pulmonary Hypertension (CTREPH)

NCT01416636 is registered in ClinicalTrials.gov with SciPharm SàRL as lead sponsor.

NCT NCT01416636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01416636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Controlled Clinical Study to Investigate the Efficacy and Tolerability of Subcutaneous Treprostinil Sodium in Patients With Severe Non-operable Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
Lead sponsor
SciPharm SàRL
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2009
Completion date
April 30, 2021
Enrollment
105 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

non-operable chronic thromboembolic pulmonary hypertension